Rallybio Corp (RLYB) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $31.37M | +125.7% |
| 2024 | $13.90M | -43.2% |
| 2023 | $24.49M | -57.0% |
| 2022 | $56.96M | -67.5% |
| 2021 | $175.33M | +25.0% |
| 2020 | $140.23M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $31.37M | +125.7% |
| 2024 | $13.90M | -43.2% |
| 2023 | $24.49M | -57.0% |
| 2022 | $56.96M | -67.5% |
| 2021 | $175.33M | +25.0% |
| 2020 | $140.23M | — |